Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Rick Strange who wrote (872)	6/3/1998 10:58:00 AM
From: yosi s	Read Replies (1) \| Respond to of 1491

>how do you test this on human subjects< you do not . not ethically anyway. But you can use animal studies. I have no idea how the armed forces conduct their counter measures. So it can be used but not under FDA approval.. But please remember that once a product is approve, other indication can be used "off Label"

To: Rick Strange who wrote (872)	6/3/1998 11:51:00 AM
From: Ariella	Respond to of 1491

Rick -- I have sent this question to Gina Kolata, senior science editor at The New York Times. The answer is probably what Yosi said, but it can't hurt to ask it since the asking also is a form of news dissemination. Fear of nerve-gas is not just an army problem. If I lived in Israel and thought this product would help, I'd want to keep a syringe in the house just in case Hussein started making threats again. I'd keep it if I knew it did not itself cause brain/nervous system damage, just in the hope it would help in such an extreme situation. Safety factors for human use are being addressed in the other HU-211 trials. --Ariella